What is the maximum dose of rectal Phenergan (promethazine) for treating uncontrolled nausea and vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Rectal Promethazine for Uncontrolled Nausea and Vomiting

The maximum dose of rectal promethazine for treating uncontrolled nausea and vomiting is 25 mg per dose, which may be repeated every 4-6 hours as necessary, with a total daily maximum of 100 mg. 1

Specific Dosing Guidelines

Standard Dosing for Nausea and Vomiting

  • The FDA-approved dose for active therapy of nausea and vomiting is 25 mg per dose 1
  • Doses of 12.5-25 mg may be repeated at 4-6 hour intervals as necessary 1
  • The total dose range is 25-100 mg daily, which may be used as adjuvant therapy 2, 3

Route Selection for Uncontrolled Symptoms

  • When oral medication cannot be tolerated due to ongoing vomiting, rectal suppository administration is the preferred route 1
  • The rectal route is specifically recommended for breakthrough emesis when the oral route is not feasible 2

Pharmacokinetic Considerations

Onset and Duration

  • Clinical effects are evident within 5 minutes of administration (IV data), with duration of action of 4-6 hours 2, 3
  • The plasma half-life is 9-16 hours, which supports the 4-6 hour dosing interval 2, 3

Dosing Frequency Rationale

  • The 4-6 hour interval between doses is based on the duration of action, not the half-life 1
  • This allows for adequate symptom control while minimizing cumulative sedative effects

Important Safety Considerations

Adverse Effects to Monitor

  • Promethazine causes significant sedation, hypotension (especially with rapid administration), and extrapyramidal effects including neuroleptic malignant syndrome 2, 3
  • Sedation is dose-dependent and can be substantial, particularly when combined with opioid analgesics 4, 5

Contraindications

  • Promethazine is contraindicated in children under 2 years of age due to risk of fatal respiratory depression 1

Clinical Efficacy Evidence

Effectiveness Data

  • Promethazine 25 mg suppositories demonstrated 89% usage rate among patients with post-discharge nausea/vomiting, with all users reporting symptom improvement 6
  • In comparative studies, promethazine 25 mg IV showed similar antiemetic efficacy to ondansetron 4 mg, though with greater sedation 5

Lower Dose Considerations

  • Studies demonstrate that lower doses (6.25-12.5 mg IV) provide equivalent antiemetic efficacy with reduced sedation 4, 7
  • However, the FDA-approved rectal dosing remains 12.5-25 mg per dose 1

Practical Algorithm for Dosing

Initial dose: 25 mg rectal suppository 1

If inadequate response after 4-6 hours: Repeat 25 mg dose 1

Maximum frequency: Every 4-6 hours 1

Daily maximum: 100 mg total 2, 3

If symptoms persist despite maximum dosing: Add a second antiemetic from a different drug class (5-HT3 antagonist like ondansetron, or NK-1 antagonist) rather than exceeding promethazine maximum 2

Common Pitfalls to Avoid

  • Do not exceed 25 mg per rectal dose - higher single doses increase sedation without improving antiemetic efficacy 1
  • Do not dose more frequently than every 4 hours - this increases risk of excessive sedation and extrapyramidal effects 1
  • Consider around-the-clock scheduled dosing rather than PRN for severe, ongoing symptoms 2
  • Avoid combining with other CNS depressants without dose adjustment - promethazine potentiates sedative effects of opioids and benzodiazepines 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Promethazine Administration and Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ondansetron versus promethazine to treat acute undifferentiated nausea in the emergency department: a randomized, double-blind, noninferiority trial.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2008

Research

A comparison of two differing doses of promethazine for the treatment of postoperative nausea and vomiting.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.